GMO

Est. 1977
201-500 employees Investment Management

About GMO

For more than 40 years, GMO has partnered with a broad range of sophisticated institutions, financial intermediaries, and families to provide the investment expertise they need to meet their goals and fulfill their missions.
Investing on behalf of our clients is GMO’s sole focus. Across asset classes and around the world, our investment teams identify and exploit long-term opportunities and develop solutions that both anticipate and respond to client needs.
GMO is comprised of a collection of investment teams with focused specialties. All are grounded in a long-term, valuation-based investment philosophy – an approach we believe provides the best risk-adjusted returns.
GMO partners with an impressive roster of sophisticated clients worldwide, delivering innovative investment solutions and tailored client service. Our clients benefit from our diverse expertise, intellectual curiosity, and open culture of debate, as well as from our ability and willingness to take advantage of contrarian market opportunities. For important disclosure information please visit: https://www.gmo.com/americas/terms-and-conditions/

Understanding Liquid Alternatives
  • 17 Sep 2026

B.J. Brannan and Catherine LeGraw of GMO’s Asset Allocation team discuss how liquid alternative strategies can provide diversification, alpha potential, and daily liquidity within a multi-asset por...

THE EVOLUTION AND EDGE OF GMO SYSTEMATIC EQUI...
  • 05 Aug 2026

What creates a durable edge in systematic equity investing? GMO examines the research, valuation framework, and portfolio construction behind its approach.

THE LIQUID ALTERNATIVES REVIVAL
  • 29 Jul 2026

As the Goldilocks era ends, liquidity and true diversification matter more. GMO explores why liquid alternatives deserve a fresh look.

THE ELECTRICITY TIPPING POINT & THE NEXT ENER...
  • 23 Jul 2026

Surging electricity demand is reshaping the energy landscape, creating opportunities for investors across a wide variety of industries.

VALUATION METRICS IN EMERGING DEBT: 2Q26
  • 23 Jul 2026

In GMO’s latest Quarterly Valuation Update, FX and local currency rates screen cheap and very cheap, while hard currency credit is rich.

GMO 7-YEAR ASSET CLASS FORECAST: 2Q 2026
  • 20 Jul 2026

GMO's 7-Year Asset Class Forecast as of June 30, 2026.

TARGETING OUTCOMES
  • 15 Jul 2026

Emerging market debt is broad and inefficient. We examine when a total return, cash‑plus approach may better align portfolios with desired outcomes.

MID-YEAR UPDATE: EQUITY DISLOCATION STRATEGY
  • 13 Jul 2026

GMO's Equity Dislocation Strategy has gotten off to a strong start in H1 2026. Our mid-year update explores how valuation discipline and active rotation shaped performance amid AI-driven volatility.

GMO 7-YEAR ASSET CLASS FORECAST: MAY 2026
  • 12 Jun 2026

GMO's 7-Year Asset Class Forecast as of May 31, 2026.